Companies / Germany
Polpharma A Target For Stada?
July 2006 | Company News AlertGerman generic firm Stada - which is currently in the process of buying Serbia's Hemofarm - has stated that it is interested in further acquisitions in the region, ideally in the Czech Republic, Turkey or Poland, and hinted that Polpharma may be a target.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
